Fulcrum Therapeutics, Inc. (FULC): Price and Financial Metrics
Fulcrum Therapeutics, Inc. (FULC)
Today's Latest Price: $17.85 USD
0.78 (4.57%)
Updated Jul 2 4:00pm
Add FULC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
FULC Daily Price Range
FULC 52-Week Price Range
FULC Stock Price Chart Technical Analysis Charts
FULC Price/Volume Stats
| Current price | $17.85 | 52-week high | $22.96 |
| Prev. close | $17.07 | 52-week low | $4.37 |
| Day low | $17.32 | Volume | 49,748 |
| Day high | $19.00 | Avg. volume | 90,719 |
| 50-day MA | $17.35 | Dividend yield | N/A |
| 200-day MA | $13.51 | Market Cap | 417.21M |
Fulcrum Therapeutics, Inc. (FULC) Company Bio
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.
Loading social stream, please wait...